Deutsche Bank Ag\ Adverum Biotechnologies, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.75 - $1.26 $13 - $22	18 New	18 $0
Q2 2022 Aug 11, 2022	SELL	$0.81 - $1.34 $38,199 - $63,194	-47,160 Reduced 99.96%	18 $0
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $6,885 - $10,916	-5,598 Reduced 10.61%	47,178 $62,000
Q4 2021 Feb 11, 2022	BUY	$1.74 - $2.4 $4,851 - $6,691	2,788 Added 5.58%	52,776 $93,000
Q3 2021 Nov 04, 2021	SELL	$2.08 - $3.6 $1 Million - $1.74 Million	-482,942 Reduced 90.62%	49,988 $108,000
Q2 2021 Aug 11, 2021	BUY	$3.36 - $10.56 $1.55 Million - $4.86 Million	460,517 Added 635.96%	532,930 $1.87 Million
Q1 2021 May 13, 2021	SELL	$9.26 - $14.36 $155,660 - $241,391	-16,810 Reduced 18.84%	72,413 $713,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $9.36 Million - $13.6 Million	-951,592 Reduced 91.43%	89,223 $967,000
Q3 2020 Nov 12, 2020	BUY	$10.3 - $21.64 $10.3 Million - $21.6 Million	997,562 Added 2306.34%	1,040,815 $10.7 Million
Q2 2020 Aug 13, 2020	SELL	$8.53 - $25.64 $525,140 - $1.58 Million	-61,564 Reduced 58.73%	43,253 $903,000
Q1 2020 May 14, 2020	SELL	$7.98 - $16.32 $917,356 - $1.88 Million	-114,957 Reduced 52.31%	104,817 $1.03 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $685,096 - $1.64 Million	133,808 Added 155.65%	219,774 $2.53 Million
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $274,879 - $833,557	52,458 Added 156.55%	85,966 $467,000
Q2 2019 Aug 14, 2019	SELL	$5.1 - $11.89 $169,223 - $394,522	-33,181 Reduced 49.75%	33,508 $397,000
Q1 2019 May 15, 2019	SELL	$3.03 - $6.02 $163,026 - $323,900	-53,804 Reduced 44.65%	66,689 $347,000
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $220,246 - $454,306	-76,741 Reduced 38.91%	120,493 $379,000
Q3 2018 Dec 21, 2021	BUY	$4.5 - $7.6 $79,821 - $134,808	17,738 Added 9.88%	197,234 $1.19 Million
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $673,839 - $1.14 Million	-149,742 Reduced 45.48%	179,496 $1.08 Million
Q2 2018 Apr 21, 2020	BUY	$5.3 - $6.9 $105,183 - $136,937	19,846 Added 6.41%	329,238 $1.74 Million
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $272,706 - $355,032	51,454 Added 19.95%	309,392 $1.64 Million
Q1 2018 Oct 18, 2019	BUY	$3.65 - $7.95 $12,045 - $26,235	3,300 Added 1.3%	257,938 $1.5 Million
Q1 2018 May 15, 2018	SELL	$3.65 - $7.95 $469,725 - $1.02 Million	-128,692 Reduced 33.57%	254,638 $1.48 Million
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $561,122 - $777,695	196,885 Added 105.6%	383,330 $1.34 Million
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $456,790 - $680,524	186,445	186,445 $680,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account